Cargando…
Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations
Rezafungin is a novel once-weekly echinocandin for intravenous injection currently in development for the treatment of Candida infections and the prevention of Candida, Aspergillus, and Pneumocystis infections in allogeneic blood and marrow transplant recipients. While in vitro data indicated that r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269561/ https://www.ncbi.nlm.nih.gov/pubmed/37154682 http://dx.doi.org/10.1128/spectrum.01339-23 |